T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Bitdeer Technologies
BTDR
$3.05B
| $1.72M | ﹤0.01% |
108,054
+20,977
| +24% | +$301K |
|
2077
US Physical Therapy
USPH
$1.29B
| $1.71M | ﹤0.01% |
24,928
+9,072
| +57% | +$616K |
|
2078
NovaGold Resources
NG
$2.97B
| $1.71M | ﹤0.01% |
286,504
+86,135
| +43% | +$717K |
|
2079
Ibotta
IBTA
$841M
| $1.71M | ﹤0.01% |
49,983
+1,219
| +2% | +$40.7K |
|
2080
Live Oak Bancshares
LOB
$1.73B
| $1.7M | ﹤0.01% |
41,528
+8,403
| +25% | +$314K |
|
2081
Apogee Enterprises
APOG
$774M
| $1.69M | ﹤0.01% |
37,002
+5,971
| +19% | +$223K |
|
|
CSR
2082
Centerspace
CSR
$924M
| $1.69M | ﹤0.01% |
30,066
+5,721
| +23% | +$361K |
|
2083
Merchants Bancorp
MBIN
$2.39B
| $1.69M | ﹤0.01% |
33,798
+6,020
| +22% | +$286K |
|
2084
Compass Minerals
CMP
$937M
| $1.69M | ﹤0.01% |
54,209
+8,878
| +20% | +$251K |
|
2085
Independent Bank Corp
IBCP
$795M
| $1.69M | ﹤0.01% |
46,792
+8,219
| +21% | +$281K |
|
|
AAMI
2086
Acadian Asset Management
AAMI
$3.33B
| $1.69M | ﹤0.01% |
23,568
+3,563
| +18% | +$248K |
|
2087
Aurinia Pharmaceuticals
AUPH
$2.18B
| $1.69M | ﹤0.01% |
99,276
+13,054
| +15% | +$209K |
|
2088
uniQure
QURE
$2.6B
| $1.68M | ﹤0.01% |
36,524
+6,077
| +20% | +$159K |
|
2089
Talos Energy
TALO
$2.78B
| $1.68M | ﹤0.01% |
129,968
+14,202
| +12% | +$212K |
|
2090
Cannae Holdings
CNNE
$678M
| $1.67M | ﹤0.01% |
115,820
+16,144
| +16% | +$219K |
|
2091
Alkami Technology
ALKT
$1.46B
| $1.67M | ﹤0.01% |
91,879
+18,787
| +26% | +$310K |
|
2092
James River Group Holdings
JRVR
$161M
| $1.66M | ﹤0.01% |
376,537
+11,960
| +3% | +$58.9K |
|
2093
Burke & Herbert Financial Services Corp
BHRB
$1.4B
| $1.65M | ﹤0.01% |
22,981
+4,859
| +27% | +$314K |
|
2094
Integra LifeSciences
IART
$1.25B
| $1.65M | ﹤0.01% |
91,923
+13,342
| +17% | +$187K |
|
|
TECX
2095
Tectonic Therapeutic
TECX
$459M
| $1.65M | ﹤0.01% |
48,001
-116,054
| -71% | -$3.41M |
|
2096
Sylvamo
SLVM
$1.41B
| $1.65M | ﹤0.01% |
43,618
+6,493
| +17% | +$263K |
|
2097
Enovis
ENOV
$1.04B
| $1.64M | ﹤0.01% |
79,418
+9,743
| +14% | +$230K |
|
|
LADR
2098
Ladder Capital
LADR
$1.15B
| $1.64M | ﹤0.01% |
165,202
+22,641
| +16% | +$230K |
|
2099
Trevi Therapeutics
TRVI
$2.04B
| $1.64M | ﹤0.01% |
88,057
+23,354
| +36% | +$340K |
|
2100
Cerence
CRNC
$351M
| $1.64M | ﹤0.01% |
144,468
+8,493
| +6% | +$83.2K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.